Patient health and safety advocates and the biopharmaceutical industry share a commitment to improve patient care and safety to removing obstacles to physician-prescribed medications. At the recent BIO Patient and Health Advocacy Summit, advocates and industry met to discuss these shared concerns. Representatives from the Physician-Patient Alliance for Health & Safety attended the Summit.

There were two major key concerns discussed:

Continue reading “Obstacles to Physician-Prescribed Medications – Cost, Delays, and Denials” →